Dear Subscriber,
Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
MRI Scans Funded For Younger Women At High Risk Of Breast Cancer, Australia
http://www.medicalnewstoday.com/articles/134002.php
National Breast and Ovarian Cancer Centre welcomes the addition of two new items to the Medicare Benefits Schedule (MBS) for the use of Magnetic Resonance Imaging (MRI) in the surveillance and diagnosis of women under 50 years of age at high risk of developing breast cancer.
----------------------------------------------
** CANCER / ONCOLOGY News **
Oncology Specialists Get More Connected With Patients - National Cancer Action Team Programme
http://www.medicalnewstoday.com/articles/134019.php
An innovative experiental programme to help cancer clinicians improve communication with patients and their families has just been launched by the National Cancer Action Team (NCAT). The NCAT communication skills programme, 'Connected', is designed to equip senior healthcare professionals in oncology with the communication skills necessary for the delivery of high-quality care.
Cancer Institute Of New Jersey Receives Nearly $768,000 To Investigate A New Therapeutic Path Against Melanoma
http://www.medicalnewstoday.com/articles/133917.php
With 2,300 New Jersey residents diagnosed with melanoma this year, the Garden State ranks sixth in the nation in new cases of the disease, according to the American Cancer Society. It is that statistic on which a scientist at The Cancer Institute of New Jersey (CINJ) hopes to have impact, thanks to a $768,000 grant awarded by the American Cancer Society to study melanoma development.
Newly Found Enzymes May Play Early Role In Cancer - Zebrafish Study Suggests New Targeted Treatment
http://www.medicalnewstoday.com/articles/133916.php
Researchers have discovered two enzymes that, whencombined, could be involved in the earliest stages of cancer. Manipulatingthese enzymes genetically might lead to targeted therapies aimed at slowingor preventing the onset of tumors.
Paediatric Patient Treated Using RapidArc™ Radiotherapy Technology In Switzerland
http://www.medicalnewstoday.com/articles/133914.php
A Swiss cancer clinic is among the first in the world to use a new, faster radiotherapy technology from Varian Medical Systems (NYSE: VAR) to treat a child patient. A 12-year-old girl with Hodgkin's lymphoma was treated using Varian's RapidArc™ technique at the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona.
Study Of New Drug To Stimulate Immune System Of Cancer Victims: TGen, Scottsdale Healthcare, Mayo Clinic
http://www.medicalnewstoday.com/articles/133889.php
The Translational Genomics Research Institute (TGen), Scottsdale Healthcare and Mayo Clinic are testing a new drug that could help cancer patients by stimulating the immune system.Clinical trials of the drug VTX-2337 are being conducted at TGen Clinical Research Services at Scottsdale Healthcare, a partnership of Phoenix-based TGen and Scottsdale-based Scottsdale Healthcare Corp.
First Lung Lesion And First Lymph Node Metastasis Treated With AngioDynamics' IRE Technology At Australia's The Alfred Hospital
http://www.medicalnewstoday.com/articles/133852.php
AngioDynamics, Inc. (NASDAQ:ANGO) announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case, at The Alfred in Melbourne, Australia.
Clinical Outcome Following Prostatic Capsule- And Seminal-Sparing Cystectomy For Bladder Cancer In 25 Men
http://www.medicalnewstoday.com/articles/133754.php
UroToday.com - In a recent article in the <i>Scandinavian Journal of Urology and Nephrology</i>, the authors evaluated the long-term outcomes of 25 men who underwent a prostate capsule- and seminal-sparing cystectomy.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
First Lung Lesion And First Lymph Node Metastasis Treated With AngioDynamics' IRE Technology At Australia's The Alfred Hospital
http://www.medicalnewstoday.com/articles/133852.php
AngioDynamics, Inc. (NASDAQ:ANGO) announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case, at The Alfred in Melbourne, Australia.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Paediatric Patient Treated Using RapidArc™ Radiotherapy Technology In Switzerland
http://www.medicalnewstoday.com/articles/133914.php
A Swiss cancer clinic is among the first in the world to use a new, faster radiotherapy technology from Varian Medical Systems (NYSE: VAR) to treat a child patient. A 12-year-old girl with Hodgkin's lymphoma was treated using Varian's RapidArc™ technique at the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Ingredient In Cough Medicine Could Effectively Treat Prostate Cancer
http://www.medicalnewstoday.com/articles/133891.php
A study published in the December issue of the European medical journal <i>Anticancer Research</i> demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
